Library Logo

Clinical chemistry, immunology and laboratory quality control : a comprehensive review for board preparation, certification and clinical practice / (Record no. 246860)

000 -LEADER
fixed length control field 09513cam a2200589Mi 4500
001 - CONTROL NUMBER
control field ocn879866913
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190328114807.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr un|---uuuua
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140429s2014 cauadf ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency GGVRL
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency GGVRL
Modifying agency OCLCO
-- GWM
-- OCLCF
-- YDXCP
-- EBLCP
-- OPELS
-- N$T
-- COO
-- Z5A
-- OCLCQ
-- TEFOD
-- ESU
-- OCLCQ
-- YDX
-- CASUM
-- OCLCQ
-- U3W
-- D6H
-- WYU
066 ## - CHARACTER SETS PRESENT
Alternate G0 or G1 character set (S
019 ## -
-- 865333555
-- 870332576
-- 932129074
-- 956670909
-- 988823533
-- 1006797465
-- 1011200826
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780124079359
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0124079350
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0124078214
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780124078215
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)879866913
Canceled/invalid control number (OCoLC)865333555
-- (OCoLC)870332576
-- (OCoLC)932129074
-- (OCoLC)956670909
-- (OCoLC)988823533
-- (OCoLC)1006797465
-- (OCoLC)1011200826
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RB40
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.0756
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dasgupta, Amitava,
Dates associated with a name 1958-
Relator term author.
245 10 - TITLE STATEMENT
Title Clinical chemistry, immunology and laboratory quality control : a comprehensive review for board preparation, certification and clinical practice /
Medium [electronic resource]
Statement of responsibility, etc. Amitava Dasgupta, PhD, DABCC, Professor of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Amer Wahed, MD, Assistant Professor of Pathology and Laboratory Medicine, University of Texas Medical School at Houston.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture San Diego, CA :
Name of producer, publisher, distributor, manufacturer Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice 2014.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xx, 483 pages, 4 unnumbered pages of plates) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Linkage 880-01
Formatted contents note Chapter 1. Instrumentation and analytical methods -- chapter 2. Immunoassay platform and designs -- chapter 3. Pre-analytical variables -- chapter 4. Laboratory statistics and quality control -- chapter 5. Water, homeostasis, electrolytes, and acid-base balance -- chapter 6. Lipid metabolism and disorders -- chapter 7. Carbohydrate metabolism, diabetes, and hypoglycemia -- chapter 8. Cardiac markers -- chapter 9. Endocrinology -- chapter 10. Liver diseases and liver function tests -- chapter 11. Renal function tests -- chapter 12. Inborn errors of metabolism -- chapter 13. Tumor markers -- chapter 14. Therapeutic drug monitoring -- chapter 15. Interferences in therapeutic drug monitoring -- chapter 16. Drugs of abuse testing -- chapter 17. Challenges in drugs of abuse testing : magic mushrooms, peyote cactus, and designer drugs -- chapter 18. Testing for ethyl alcohol (alcohol) and other volatiles -- chapter 19. Common poisonings including heavy metal poisoning -- chapter 20. Pharmacogenomics -- chapter 21. Hemoglobinopathy -- chapter 22. Protein electrophoresis and immunofixation -- chapter 23. Human immunodeficiency virus (HIV) and hepatitis testing -- chapter 24. Autoimmunity, complement, and immunodeficiency -- chapter 25. Effect of herbal supplements on clinical laboratory test results.
520 ## - SUMMARY, ETC.
Summary, etc. All pathology residents must have a good command of clinical chemistry, toxicology, immunology, and laboratory statistics to be successful pathologists, as well as to pass the American Board of Pathology examination. This book presents core topics and detailed case studies that illustrate the application of clinical chemistry knowledge to everyday patient care and offers practical examples of how things function in the pathology clinic.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical chemistry.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical chemistry
Form subdivision Case studies.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element HEALTH & FITNESS
General subdivision Diseases
-- General.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Clinical Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Diseases.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Evidence-Based Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Internal Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical chemistry.
Source of heading or term fast
Authority record control number (OCoLC)fst00864330
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Case studies.
Source of term fast
Authority record control number (OCoLC)fst01423765
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wahed, Amer,
Relator term author.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Dasgupta, Amitava.
Title Clinical Chemistry, Immunology and Laboratory Quality Control : A Comprehensive Review for Board Preparation, Certification and Clinical Practice.
Place, publisher, and date of publication Burlington : Elsevier Science, �2013
International Standard Book Number 9780124078215
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect
Uniform Resource Identifier http://www.sciencedirect.com/science/book/9780124078215
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect
Uniform Resource Identifier https://www.sciencedirect.com/science/book/9780124078215
880 00 - ALTERNATE GRAPHIC REPRESENTATION
Linkage 505-01/(S
g 8.8.
t B-Type Natriuretic Peptides (BNP) --
g 8.9.
t C-Reactive Protein --
g 8.10.
t Myeloperoxidase --
-- Key Points --
-- References --
g 9.1.
t Introduction to Various Endocrine Glands --
g 9.2.
t Hypothalamus --
g 9.3.
t Pituitary Gland --
g 9.4.
t Thyroid Gland --
g 9.5.
t Thyroid Function Tests --
g 9.6.
t Hypothyroidism --
g 9.7.
t Hyperthyroidism --
g 9.8.
t Disorders of Parathyroid Glands --
g 9.9.
t Adrenal Glands --
g 9.10.
t Cushing's Syndrome --
g 9.11.
t Conn's Syndrome --
g 9.12.
t Hypoadrenalism Including Addison's Disease --
g 9.13.
t Dysfunctions of Gonads --
g 9.14.
t Pancreatic Endocrine Disorders --
g 9.15.
t Multiple Endocrine Neoplasias --
g 9.16.
t Endocrine Testings: Suppression and Stimulation Tests --
-- Key Points --
-- References --
g 10.1.
t Liver Physiology --
g 10.2.
t Liver Function Tests and Interpretations --
g 10.3.
t Jaundice: An Introduction --
g 10.4.
t Congenital Hyperbilirubinemia --
g 10.5.
t Hemolytic (Prehepatic) Jaundice --
g 10.6.
t Hepatocellular Jaundice --
g 10.7.
t Chronic Liver Disease --
g 10.8.
t Cholestatic Jaundice --
g 10.9.
t Alcohol- and Drug-Induced Liver Disease --
g 10.10.
t Liver Disease in Pregnancy --
g 10.11.
t Liver Disease in Neonates and Children --
g 10.12.
t Macro Liver Enzymes --
g 10.13.
t Laboratory Measurement of Bilirubin and Other Tests --
-- Key Points --
-- References --
g 11.1.
t Basic Functions of Kidneys --
g 11.2.
t Glomerular Filtration Rate --
g 11.3.
t Creatinine Clearances --
g 11.4.
t Chronic Kidney Disease --
g 11.5.
t Cystatin C --
g 11.6.
t Urea (Blood Urea Nitrogen) and Uric Acid --
g 11.7.
t Protein in Urine and Proteinuria --
g 11.8.
t Other Renal Diseases --
g 11.9.
t Laboratory Measurements of Creatinine and Related Tests --
g 11.10.
t Urine Dipstick Analysis --
-- Key Points --
-- References --
g 12.1.
t Overview of Inborn Errors of Metabolism --
g 12.2.
t Amino Acid Disorders --
g 12.2.1.
t Phenylketonuria --
g 12.2.2.
t Maple Syrup Urine Disease (MSUD) --
g 12.2.3.
t Other Amino Acid Disorders --
g 12.3.
t Carbohydrate Metabolism Disorders --
g 12.3.1.
t Galactosemia --
g 12.3.2.
t Glycogen Storage Disease --
g 12.3.3.
t Fructose Intolerance --
g 12.3.4.
t Lactose Intolerance --
g 12.4.
t Urea Cycle Disorders --
g 12.5.
t Organic Acid Disorders (Organic Aciduria) --
g 12.6.
t Fatty Acid Oxidation Disorders --
g 12.7.
t Mitochondrial Disorders --
g 12.8.
t Peroxisomal Disorders --
g 12.9.
t Lysosomal Storage Disorders --
g 12.10.
t Purine or Pyrimidine Metabolic Disorders --
g 12.11.
t Disorders of Porphyrin Metabolism --
g 12.12.
t Newborn Screening and Evaluation --
-- Key Points --
-- References --
g 13.1.
t Introduction to Tumor Markers --
g 13.2.
t Clinical Uses of Tumor Markers and Common Tumor Markers --
g 13.3.
t Prostate-Specific Antigen (PSA) --
g 13.4.
t False Positive and Unexpected PSA Results --
g 13.5.
t Cancer Antigen 125 (Carbohydrate Antigen 125: CA-125) --
g 13.6.
t False Positive CA-125 --
g 13.7.
t Alpha-Fetal Protein --
g 13.8.
t False Positive AFP --
g 13.9.
t Carcinoembryonic Antigen (CEA) --
g 13.10.
t False Positive CEA --
g 13.11.
t Cancer Antigen-19-9 --
g 13.12.
t (Sb(B2-Microglobulin --
g 13.13.
t Human Chorionic Gonadotropin (hCG) --
g 13.14.
t Causes and Evaluation of Persistent Low Levels of hCG --
g 13.15.
t False Positive hCG --
-- Key Points --
-- References --
g 14.1.
t What is Therapeutic Drug Monitoring--
g 14.2.
t Drugs That Require Therapeutic Drug Monitoring --
g 14.3.
t Free Versus Total Drug Monitoring --
g 14.4.
t Therapeutic Drug Monitoring Benefits --
g 14.5.
t Basic Pharmacokinetics --
g 14.6.
t Effect of Gender and Pregnancy on Drug Metabolism and Disposition --
g 14.7.
t Effect of Age on Drug Metabolism and Disposition --
g 14.8.
t Drug Metabolism and Disposition in Uremia --
g 14.9.
t Drug Metabolism and Disposition in Liver Disease --
g 14.10.
t Effect of Cardiovascular Disease on Drug Metabolism and Disposition --
g 14.11.
t Thyroid Dysfunction and Drug Metabolism --
g 14.12.
t Effect of Food, Alcohol Consumption, and Smoking on Drug Disposition --
g 14.13.
t Monitoring of Various Drug Classes: General Considerations --
g 14.14.
t Monitoring of Anticonvulsants --
g 14.15.
t Monitoring of Cardioactive Drugs --
g 14.16.
t Monitoring of Anti-Asthmatic Drugs --
g 14.17.
t Monitoring of Antidepressants --
g 14.18.
t Monitoring of Immunosuppressants --
g 14.19.
t Monitoring of Selected Antibiotics --
g 14.20.
t Monitoring of Antineoplastic Drugs --
g 14.21.
t Monitoring of Antiretrovirals --
-- Key Points --
-- References --
g 15.1.
t Methodologies Used in Therapeutic Drug Monitoring and Issues of Interferences --
g 15.2.
t Effect of Endogenous Factors on Therapeutic Drug Monitoring --
g 15.3.
t Effect of Collecting Specimen in Gel-Separator Tube on Therapeutic Drug Monitoring Results --
g 15.4.
t Digoxin Immunoassays: So Much Interference --
g 15.5.
t Interferences in Analysis of Antiepileptics --
g 15.6.
t Interferences in Analysis of Tricyclic Antidepressants --
g 15.7.
t Interferences in Analysis of Immunosuppressants.

No items available.

Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login